Pegylated recombinant human epidermal growth factor (rhEGF) for sustained release from biodegradable PLGA microspheres.

Recombinant human epidermal growth factor (rhEGF) was conjugated with polyethylene glycol (PEG) to improve its physical stability during microencapsulation in biodegradable poly(lactic-co-glycolic acid) microspheres. rhEGF was conjugated with N-hydroxysuccimide (NHS)-derivatized methoxy-PEG (mPEG) of MW 2000 and 5000 under various reaction conditions to optimize the extent of pegylation. Pegylated rhEGF showed much enhanced physical stability against homogenization. Pegylated rhEGF was encapsulated in PLGA microspheres by a double emulsion solvent evaporation method to achieve a sustained release. Pegylated rhEGF exhibited a tri-phasic release profile with a reduced initial burst, compared with unpegylated rhEGF. This study demonstrated that protein pegylation enhanced physical stability of protein and could be a good approach to achieve a sustained protein release profile from biodegradable microspheres.

[1]  R. Bartus,et al.  Sustained Delivery of Proteins for Novel Therapeutic Products , 1998, Science.

[2]  C. Patrick,et al.  Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique. , 2000, Journal of biomedical materials research.

[3]  R Langer,et al.  Controlled and modulated release of basic fibroblast growth factor. , 1991, Biomaterials.

[4]  T. Park,et al.  Protein release from poly(lactic-co-glycolic acid) microspheres: protein stability problems. , 1995, PDA journal of pharmaceutical science and technology.

[5]  D. Brems,et al.  Characterization and Stability of N-terminally PEGylated rhG-CSF , 1996, Pharmaceutical Research.

[6]  J. Taylor,et al.  Epidermal growth factor. Physical and chemical properties. , 1972, The Journal of biological chemistry.

[7]  T. Park,et al.  Adsorption determines in-vitro protein release rate from biodegradable microspheres: quantitative analysis of surface area during degradation , 1997 .

[8]  M. Przybylski,et al.  Structural characterization and biological activity of recombinant human epidermal growth factor proteins with different N-terminal sequences. , 1994, Biochimica et biophysica acta.

[9]  L. Meinel,et al.  Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[10]  A. Oliff,et al.  Isolation of multiple biologically and chemically diverse species of epidermal growth factor , 1987, Peptides.

[11]  S. Schwendeman,et al.  Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide) , 2000, Nature Biotechnology.

[12]  A. Butler,et al.  Acquisition and utilization of transition metal ions by marine organisms. , 1998, Science.

[13]  S. Cohen,et al.  The primary structure of epidermal growth factor. , 1972, The Journal of biological chemistry.

[14]  R Langer,et al.  Localized delivery of epidermal growth factor improves the survival of transplanted hepatocytes , 1996, Biotechnology and bioengineering.

[15]  D. Brems,et al.  PEGylation Prevents the N-Terminal Degradation of Megakaryocyte Growth and Development Factor , 1998, Pharmaceutical Research.

[16]  J. Wozney,et al.  Potential of porous poly-D,L-lactide-co-glycolide particles as a carrier for recombinant human bone morphogenetic protein-2 during osteoinduction in vivo. , 1999, Journal of biomedical materials research.

[17]  X. Li,et al.  Influence of process parameters on the protein stability encapsulated in poly-DL-lactide-poly(ethylene glycol) microspheres. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[18]  T. Park,et al.  Stability and release of bovine serum albumin encapsulated within poly(d,l-lactide-co-glycolide) microparticles , 1996 .

[19]  T. Park,et al.  Microencapsulation of human growth hormone within biodegradable polyester microspheres: protein aggregation stability and incomplete release mechanism. , 1999, Biotechnology and bioengineering.

[20]  G. Gill,et al.  Increased phosphotyrosine content and inhibition of proliferation in EGF-treated A431 cells , 1981, Nature.

[21]  I. Campbell,et al.  Human epidermal growth factor , 1992 .

[22]  R. Kenley,et al.  Poly(lactide-co-glycolide) decomposition kinetics in vivo and in vitro , 1987 .

[23]  T. Park,et al.  Pegylation enhances protein stability during encapsulation in PLGA microspheres. , 2001, Journal of controlled release : official journal of the Controlled Release Society.